Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-27 Sale | 2023-01-31 4:21 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 610 | $20.26 | $12,359 | 18,751 (Direct) | View |
| 2023-01-09 Sale | 2023-01-09 5:13 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 469 | $20.2 | $9,474 | 19,361 (Direct) | View |
| 2023-01-05 Sale | 2023-01-05 5:07 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 1,806 | $20.2 | $36,481 | 19,830 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Option Award | 2023-03-03 09:16 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 2,000 | $0 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:16 am | 2019-02-03 2029-01-02 | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 26,200 | $0 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:16 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 30,431 | $20 | 0 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 4:07 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 2,000 | $0 | 21,636 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:19 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 12,000 | $0 | 19,636 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-27 4:17 pm | N/A 2031-01-26 | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer | 18,386 | $0 | 18,386 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:09 pm | N/A 2030-01-07 | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath UK Managing Director Director | 12,400 | $0 | 17,930 (Direct) | View |
| 2019-07-29 Exercise | 2019-07-30 4:04 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath UK Managing Director Director | 30,000 | $10 | 5,530 (Indirect) | View |
| 2019-07-29 Exercise | 2019-07-30 4:04 pm | 2014-08-02 2019-08-01 | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath UK Managing Director Director | 30,000 | $0 | 5,530 (Indirect) | View |
| 2019-07-29 Tax Withholding | 2019-07-30 4:04 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath UK Managing Director Director | 24,470 | $12.26 | 5,530 (Indirect) | View |
Ownership | 2019-07-11 5:07 pm | 2014-08-02 2019-08-01 | OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath UK Managing Director Director | 0 | $0 | 147,200 (Indirect) | View |